References
- Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, et al. Hepatobiliary cancers, version 2.2019 featured updates to the NCCN guidelines. J National Compr Cancer Network. 2019;17(4):302–10.: doi:https://doi.org/10.6004/jnccn.2019.0019
- Sahu S, Sun W. Targeted therapy in biliary tract cancers-current limitations and potentials in the future. J Gastrointest Oncol. 2017;8(2):324–36. doi:https://doi.org/10.21037/jgo.2016.09.16
- Valle JW, Lamarca A, Goyal L, Barriuso J, Zhu AX. New horizons for precision medicine in biliary tract cancers. Cancer Discov. 2017;7(9):943–62. doi:https://doi.org/10.1158/2159-8290.Cd-17-0245
- Cidon EU. Resectable cholangiocarcinoma: reviewing the role of adjuvant strategies. Clin Med Insights Oncol. 2016;10:43–8. doi:https://doi.org/10.4137/cmo.S32821
- Blair AB, Murphy A. Immunotherapy as a treatment for biliary tract cancers: a review of approaches with an eye to the future. Curr Probl Cancer. 2018;42(1):49–58. doi:https://doi.org/10.1016/j.currproblcancer.2017.10.004
- Merla A, Liu KG, Rajdev L. Targeted therapy in biliary tract cancers. Curr Treat Options Oncol. 2015;16(10):48. doi:https://doi.org/10.1007/s11864-015-0366-0
- Tariq NUA, McNamara MG, Valle JW. Biliary tract cancers: current knowledge, clinical candidates and future challenges. Cancer Manag Res. 2019;11:2623–42. doi:https://doi.org/10.2147/cmar.S157092
- Gupta D, Lis CG, Vashi PG, Lammersfeld CA. Impact of improved nutritional status on survival in ovarian cancer. Support Care Cancer. 2010;18(3):373–81. doi:https://doi.org/10.1007/s00520-009-0670-y
- Ravasco P. Nutrition in cancer patients. JCM. 2019;8(8):1211. doi:https://doi.org/10.3390/jcm808
- Topalian SL, Weiner GJ, Pardoll DM. Cancer immunotherapy comes of age. J Clin Oncol. 2011;29(36):4828–36. doi:https://doi.org/10.1200/jco.2011.38.0899
- Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–5.
- Deng Y, Pang Q, Bi J-B, Zhang X, Zhang L-q, Zhou Y-Y, Miao R-C, Chen W, Qu K, Liu C, et al. A promising prediction model for survival in gallbladder carcinoma patients: pretreatment prognostic nutrient index. Tumor Biol. 2016;37(12):15773–81. doi:https://doi.org/10.1007/s13277-016-5396-0
- Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z. Prognostic nutritional index serves as a predictive marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma. Onco Targets Ther. 2016;9:6417–23. doi:https://doi.org/10.2147/ott.S112501
- Akgul O, Bagante F, Olsen G, Cloyd JM, Weiss M, et al. Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resection. J Surg Oncol. 2018;118:422–30. doi:https://doi.org/10.1002/jso.25140
- Cui P, Pang Q, Wang Y, Qian Z, Hu X, Wang W, Li Z, Zhou L, Man Z, Yang S, et al. Nutritional prognostic scores in patients with hilar cholangiocarcinoma treated by percutaneous transhepatic biliary stenting combined with 125I seed intracavitary irradiation: a retrospective observational study. Medicine (Baltimore). 2018;97(22):e11000:doi:https://doi.org/10.1097/md.0000000000011000
- Hu H-J, Jin Y-W, Zhou R-X, Ma W-J, Yang Q, Wang J-K, Liu F, Cheng N-S, Li F-Y. Clinical value of inflammation-based prognostic scores to predict the resectability of hyperbilirubinemia patients with potentially resectable hilar cholangiocarcinoma. J Gastrointest Surg. 2019;23(3):510–7. doi:https://doi.org/10.1007/s11605-018-3892-9
- Lin J, Fang T, Zhu M, Xu X, Zhang J, Zheng S, Jing C, Zhang M, Liu B, Zhang B, et al. Comparative performance of inflammation-based prognostic scores in patients operated for intrahepatic cholangiocarcinoma. Cancer Manag Res. 2019;11:9107–19. doi:https://doi.org/10.2147/cmar.S198959
- Salati M, Filippi R, Vivaldi C, Caputo F, Leone F, Salani F, Cerma K, Aglietta M, Fornaro L, Sperti E, et al. The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer. Liver Int. 2020;40(3):704–11. doi:https://doi.org/10.1111/liv.14314
- Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12. doi:https://doi.org/10.1016/j.jclinepi.2009.06.005
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. doi:https://doi.org/10.1007/s10654-010-9491-z
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88. doi:https://doi.org/10.1016/0197-2456(86)90046-2
- Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48. doi:https://doi.org/10.1093/jnci/22.4.719
- Christofi T, Baritaki S, Falzone L, Libra M, Zaravinos A. Current perspectives in cancer immunotherapy. Cancers. 2019;11(10):1472. doi:https://doi.org/10.3390/cancers1110
- Chen K-J, Zhou L, Xie H-Y, Ahmed T-E, Feng X-W, Zheng S-S. Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection. Med Oncol. 2012;29(3):1817–26. doi:https://doi.org/10.1007/s12032-011-0006-x
- Zikos TA, Donnenberg AD, Landreneau RJ, Luketich JD, Donnenberg VS. Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer. Cancer Immunol Immunother. 2011;60(6):819–27. doi:https://doi.org/10.1007/s00262-011-0996-4
- Zhou J, Ding T, Pan W, Zhu L-y, Li L, Zheng L. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients. Int J Cancer. 2009;125(7):1640–8. doi:https://doi.org/10.1002/ijc.24556
- Wigmore SJ, Plester CE, Ross JA, Fearon KC. Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg. 1997;84(2):196–7.
- Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, Enomoto K, Tanaka T, Ito M, Kurumatani N, Nakajima Y, et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol. 2013;20(8):2647–54. doi:https://doi.org/10.1245/s10434-013-2926-5
- Hu Y, Shen J, Liu R, Feng Z, Zhang C, Ling L, Chen L. Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: a systematic review and meta-analysis. Int J Biol Markers. 2018;33(4):372–8. doi:https://doi.org/10.1177/1724600818799876
- Liu J, Jiang S, Yang X, Li X, Wang N. The significant value of preoperative prognostic nutritional index for survival in pancreatic cancers: a meta-analysis. Pancreas. 2018;47(7):793–9. doi:https://doi.org/10.1097/MPA.0000000000001089
- Man Z, Pang Q, Zhou L, Wang Y, Hu X, Yang S, Jin H, Liu H. Prognostic significance of preoperative prognostic nutritional index in hepatocellular carcinoma: a meta-analysis. HPB (Oxford). 2018;20(10):888–95. doi:https://doi.org/10.1016/j.hpb.2018.03.019
- Xue Y, Zhou X, Xue L, Zhou R, Luo J. The role of pretreatment prognostic nutritional index in esophageal cancer: a meta-analysis. J Cell Physiol. 2019;234(11):19655–62. doi:https://doi.org/10.1002/jcp.28565
- Sun G, Li Y, Peng Y, Lu D, Zhang F, Cui X, Zhang Q, Li Z. Impact of the preoperative prognostic nutritional index on postoperative and survival outcomes in colorectal cancer patients who underwent primary tumor resection: a systematic review and meta-analysis. Int J Colorectal Dis. 2019;34(4):681–9. doi:https://doi.org/10.1007/s00384-019-03241-1
- Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov. 2011;10(9):712–U81. doi:https://doi.org/10.1038/nrd3439-c1